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doi:10.1016/j.ejvs.2008.03.007Abstract Objectives: Recent studies propose the use of objective risk-scoring systems as
a clinical tool for selecting patients for open or endovascular abdominal aortic aneurysm repair
(EVR). The aim of this study was to evaluate four established risk-scoring systems for accuracy
of prediction of early mortality and morbidity following EVR.
Patients and methods: 266 consecutive patients undergoing elective EVR at St. George’s Vas-
cular Institute between July 2001 and January 2007 were studied using a prospective database.
The Glasgow Aneurysm Score (GAS), the Vascular Physiology and Operative Severity Score for
the enUmeration of Mortality and Morbidity (V-POSSUM), the modified Customised Probability
Index (m-CPI) and the Customised Probability Index (CPI) were applied for prediction of 30-day
mortality and morbidity. Accuracy of prediction was compared using receiver operating
characteristics (ROC) curve analyses.
Results: 30-day mortality and morbidity rates were 4% (11/266) and 8% (22/266) respectively.
For prediction of mortality, GAS, V-POSSUM, m-CPI and CPI ROC curve analyses showed areas
under the curves (AUCs) of 0.68 (95% confidence interval (CI), 0.48-0.87; pZ 0.046), 0.66 (95%
CI, 0.51e0.81; pZ 0.067), 0.63 (95% CI, 0.45e0.81; pZ 0.148) and 0.65 (95% CI, 0.49e0.80;
pZ 0.101) respectively. Corresponding AUCs for prediction of morbidity were 0.64 (95% CI,
0.51e0.76; pZ 0.511), 0.62 (95% CI, 0.51e0.74; pZ 0.505), 0.54 (95% CI, 0.41e0.67;
pZ 0.416) and 0.55 (95% CI, 0.42e0.68; pZ 0.451).
Conclusions: GAS, V-POSSUM, m-CPI and CPI were poor predictors of early mortality and
morbidity following EVR in this series. Caution should be applied to the use of these scoring
systems for pre-operative risk stratification and treatment selection for endovascular repair
of abdominal aneurysms.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.. Thompson, St George’s Vascular Institute, 4th Floor St James’ Wing, Blackshaw Road, Tooting,
253205; fax: þ44 2087253495.
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Table 1 Risk-scoring formulas used for GAS, m-CPI and
CPI
Scoring system Formula
Glasgow Aneurysm
Score (GAS)
Age þ if CAD þ 7; CVD þ 10;
if RF þ 14
Modified Customised
Probability Index
(m-CPI)
If CAD þ13; if CCF þ14; if BP þ7;
COPD þ7; if RF þ16;
if B-blocker 15; if statin 10
Customised Probability
Index (CPI)
If CAD þ13; if CCF þ14;
if CVD þ 10; if BP þ7; if COPD þ7;
if RF þ16; if B-blocker 15;
if statin 10
CAD, coronary artery disease (MI, revascularisation, angina,
severe valve disease* or arrhythmia*); CVD, cerebrovascular
disease (stroke, TIA); RF renal failure (creatinine>180mmol/l);
CCF, uncontrolled congestive cardiac failure; COPD, chronic
obstructive pulmonary disease (<60% FEV1*); BP, treated hyper-
tension, *m-CPI only.
Risk Assessment and Endovascular Aneurysm Repair 173Introduction
Patient fitness and peri-operative risk assessment are
important factors in determining patient selection for
operative intervention. Although several objective risk
assessment scoring systems have been developed and
validated for accurate prediction of outcome after elective
open abdominal aortic aneurysm (AAA) repair, their perfor-
mance in patients undergoing endovascular aneurysm
repair (EVR) has yet to be fully evaluated.1e5
The Glasgow Aneurysm Score (GAS) was originally de-
veloped as a simple method of stratifying pre-operative risk
following open elective AAA repair, and accurately predicts
mortality in this group.1,6,7 More recently, the GAS was
evaluated as a predictor of survival following EVR in 5498
patients enrolled in the European collaborators on Stent-
graft Techniques for abdominal aortic Aneurysm Repair
(EUROSTAR) registry.8 Initial uni-variate analysis showed
pre-operative aneurysm diameter and the GAS to be associ-
ated with an increased risk of death within 30 days. How-
ever, when receiver operator curve (ROC) analyses were
performed to evaluate accuracy of mortality prediction,
the performance of the GAS was found to be poor in EURO-
STAR EVR patients, with an associated area under the curve
(AUC) of 0.70. Although this suboptimal performance was
recognised, it was subsequently proposed as an aid to
clinical decision making when considering patients with
AAA for endovascular or open repair. Furthermore, the
GAS has also been used to risk-stratify patients undergoing
EVR or open AAA repair and recommended as a clinical tool
for selecting patient treatment.9
The Customised Probability Index (CPI) was developed
for the prediction of mortality following all types of open
vascular surgery, but not endovascular techniques.3 The
type of operation was found to be a strong independent
risk factor of mortality and weighted accordingly, with
elective open AAA surgery as the highest risk (26 points),
followed by lower extremity arterial bypass surgery (15
points) and carotid surgery (0 points). The modified Cus-
tomised Probability Index (m-CPI) excluded cerebrovascu-
lar disease as an independent risk factor, expanded the
cardiac risk profile and was recently used to stratify the
fitness of 1656 patients enrolled in the EVAR trials.10 There
was no significant evidence to suggest that fitness score
influenced the benefit of EVR, and no relationship was
found between 30-day mortality and m-CPI assessment.
However, a sub-group analysis based on m-CPI-stratified
patient fitness, was used to justify the benefits of EVR re-
pair, in patients of ‘‘good fitness’’.
The Vascular Physiology and Operative Severity Score for
the enumeration of Mortality and Morbidity (V-POSSUM) is
a more complex risk scoring method using additional peri-
operative physiological data and has been used to accu-
rately predict early mortality after arterial surgery.11,12 The
performance of V-POSSUM for risk-prediction of mortality
and morbidity in EVR patients is again unknown.
Insufficient attention has been given to the validity of
risk scoring systems as applied to EVR patients when
describing the benefits of EVR in low and high-risk fitness
groups. The aim of this study was to evaluate four estab-
lished objective risk-scoring systems, GAS, CPI, m-CPI andV-POSSUM, for accuracy of prediction of early mortality and
morbidity in patients undergoing elective EVR.
Patients and Methods
Consecutive patients undergoing elective EVR at the St.
George’s Vascular Institute, a regional academic tertiary
referral centre, between July 2001 and January 2007 were
included in the study. Patients were selected for EVR on the
basis of morphological criteria, and were only excluded
from EVR repair on the basis of unsuitable aneurysm
morphology. All data required for risk scoring was collected
prospectively and entered into a comprehensive database,
including patient demographics, co-morbidities, operative
variables and outcomes, for all EVR procedures. Risk-
scoring formulae used for GAS, m-CPI and CPI are presented
in Table 1. V-POSSUM scores were calculated using a vali-
dated on-line scoring system.13
Definitions for significant in-patient morbidity were
based on recommended reporting standards for endovas-
cular aortic aneurysm repair published by the Ad Hoc
Committee for Standardized Reporting Practices in Vascular
Surgery of the Society for Vascular Surgery/American
Association for Vascular Surgery.14 Minimum inclusion
criteria for significant (moderate to severe) systemic com-
plications included cardiac (symptomatic requiring medical
intervention), pulmonary (intravenous antibiotics or pro-
longed hospitalisation), renal insufficiency (prolonged hos-
pitalisation or dialysis), cerebrovascular (delayed recovery
or CT confirmed cerebrovascular event), deep vein throm-
bosis (requiring medical intervention), pulmonary embolus
(requiring medical intervention), coagulopathy (requiring
transfusion therapy), bowel ischaemia (requiring interven-
tion), gastro-intestinal bleed (requiring endoscopic or surgi-
cal intervention), severe sepsis (documented infection with
new organ dysfunction) and spinal cord ischaemia (delayed
recovery or permanent deficit).14 Patient morbidity due to
access site complications (haematoma, infection, false an-
eurysm or lymphocele, requiring evacuation, debridement,
repair or open drainage) and post-operative arterial lower
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174 N. Bohm et al.limb complications requiring intervention were also
included.14
Statistical analysis
Statistical analysis was carried out using SPSS Version 13
(SPSS Inc., Chicago, IL, US). ROC curves were generated for
each risk-scoring system for mortality and morbidity.
Corresponding AUCs were calculated. For predictive ability,
an AUC of 0.5 is recognised as no better than chance; 0.6e
0.7 as poor; 0.7e0.8 as fair; 0.8e0.9 as good and 0.9e1.0 as
excellent.15 Tertile analyses of mortality and morbidity
were performed for all risk-score models.
Results
During this five-and-a-half-year period, 266 patients un-
derwent elective EVR for infra-renal aortic aneurysm.
Patient demographics, co-morbidities and clinical out-
comes are presented in Table 2. Eleven patients (4%) died
within 30 days of the initial procedure. Three patients
died from myocardial infarction, three from pneumonia,
one from multi-organ dysfunction, one from bowel ischae-
mia, one from an upper gastro-intestinal bleed, one from
massive retroperitoneal haemorrhage and one from aneu-
rysm rupture. Twenty-two patients (11%) developed signif-
icant post-operative morbidity. Four patients suffered
a post-operative myocardial infarction, five developed
pneumonia, seven developed renal impairment delaying
discharge and two became septic. Seven patients devel-
oped peripheral arterial complications requiring interven-
tion, one patient developed a groin haematoma requiring
surgical evacuation, a further patient returned to theatre
for debridement of a groin wound infection and one patient
suffered a significant gastro-intestinal haemorrhage.Table 2 Patient demographics, co-morbidities, risk scores
and outcomes
Number (%)
Age 73.4 (7.9)*
Aneurysm size (mm) 62.1 (16.0)*
Male 240 (90.2)
Smoker 218 (81.8)
Diabetes 33 (12.2)
Hypertension 181 (68.2)
Hypercholesterolaemia 159 (59.8)
MI/Angina 127 (47.9)
CVA/TIA 36 (13.6)
Asthma/COAD 61 (23.1)
Renal disease (serum creatinine > 135 mmol/l) 47 (17.5)
General anaesthesia 237 (89.2)
GAS 80.9 (11.0)*
V-POSSUM 20.3 (4.8)*
m-CPI 2.9 (11.2)*
CPI 3.0 (11.3)*
30-day mortality 11 (4.1)
Post-operative morbidity 22 (8.3)
* MeanS.D.
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Figure 1 Distributions of GAS, V-POSSUM, m-CPI and CPI risk
scores.
Risk Assessment and Endovascular Aneurysm Repair 175GAS, V-POSSUM, m-CPI and CPI scores were calculated in
all cases. Distributions of risk scores are shown in Fig. 1.
Mean risk scores (S.D.) were 81.4 11.0, 20.3 4.8,
2.9 11.2 and 3.0 11.3 respectively for GAS, V-POSSUM,
m-CPI and CPI. ROC curve analyses of risk scoring models
for prediction of mortality and morbidity following EVR
and corresponding AUCs are presented in Table 3. All
risk-scoring models were poor predictors of mortality
following EVR. The GAS had the highest AUC at 0.68 (95%
CI 0.48e0.87; pZ 0.046), and the least accurate predictor
of mortality was the m-CPI scoring system, with a corre-
sponding AUC of 0.63 (95% CI, 0.45e0.81; pZ 0.148). For
prediction of post-operative morbidity, all four risk-scoring
models again performed poorly. The least accurate models
for morbidity prediction were the m-CPI and CPI, with AUCs
of 0.55 (95%CI 0.42e0.68; pZ 0.509) and 0.54 (95%CI
0.41e0.67; pZ 0.451) respectively.
Results of risk-score tertile stratification for mortality
are shown in Fig. 2. Only the GAS was associated with in-
creasing tertile 30-day mortality rates, at 2.27% for patients
with a GAS less than 76, 3.41% for those with a score
between 77 and 86, and 6.82% for patients with a score
above 86. The m-CPI tertile mortality rates showed no
evidence of risk stratification for increasing scores, with
similar mortality rates in the lowest (m-CPI score <3)
and highest (m-CPI score> 7) score tertiles at 4.5%.
For morbidity, increasing score tertiles of both GAS and
V-POSSUM were associated with increasing morbidity rates
(Fig. 3). M-CPI and CPI tertile analysis showed no evidence
of risk stratification for increasing scores, with the highest
morbidity rate of 9% associated with the lowest fitness
score tertile in both groups (m-CPI and CPI score <3).Discussion
Reliable and accurate prediction of operative mortality and
morbidity is an essential pre-requisite for any risk-scoring
system used as an aid to clinical decision-making. Although
several risk-scoring systems have been derived for patients
undergoing open aortic repair, these appear to lack
accuracy when applied to EVR patients. All four risk-scoring
models in the present study performed poorly for accurate
prediction of mortality and morbidity following elective
EVR.
All-cause 30-day mortality or in-patient mortality was
chosen as the main outcome indicator, as reduction in early
mortality is a significant benefit of EVR as compared to
open AAA repair in appropriately selected patients.16 Cor-
responding performance for prediction of morbidity wasTable 3 ROC analyses performed for risk-scoring systems
Scoring
System
Mortality
AUC 95% CI p-va
GAS 0.678 0.48e0.87 0.04
V-POSSUM 0.663 0.51e0.81 0.06
m-CPI 0.629 0.45e0.81 0.14
CPI 0.646 0.49e0.81 0.10also assessed, as post-operative complications may influ-
ence longer-term post-operative outcomes.17
The only risk-scoring systems that have been previously
applied to large EVR populations are the GAS and the m-CPI
scoring systems. The average GAS score in 5498 EUROSTAR
EVR patients was similar to the mean GAS in this study, at
78.8 versus 81.4 respectively. The least accurate scoring
systems for prediction of mortality and morbidity following
EVR in this study were the m-CPI and CPI models. The m-CPI
was recently used by the UK EVAR Trial Participants to
stratify fitness in patients from the EVAR I trial to assess
outcome benefit.10 The mean m-CPI score in the present
study was comparable to the mean m-CPI score for 1252
EVAR I trial patients, at 2.9 (11.2) versus 3.6 (9.3).
The EVAR I population included 338 patients classified as
poor fitness with a mean CPI of 15.1. However, the distribu-
tion of m-CPI risk scores in both EVAR 1 and the present
study were not typical of normal populations, with the sug-
gestion of two peaks of score frequency clustering around
relatively fit and unfit patients. This questions the validity
of using a mean m-CPI score to represent overall patient
fitness in EVR populations.
Standard tertile stratifications were performed for all
risk scoring models in this series, with equal numbers of
patients in tertile groups. In contrast, the fitness score
tertiles used by the EVAR Trial Participants were adjusted
into good, moderate and poor fitness by including all
patients with m-CPI scores below zero into a much larger
good fitness group.10 Despite this adjustment, there was no
evidence to suggest that the benefit of EVR was influenced
by fitness score in EVAR I patients. Overall mortality rate in
the moderate fitness group was 2.6% compared to 1.9% in
the poor fitness group and tests of interaction between fit-
ness score and randomized group for aneurysm-related
mortality were negative. These results support the findings
in the present study, which showed no difference in
mortality rates of patients between best and worst m-CPI
risk score tertiles, with the highest morbidity rate in the
fittest tertile group. It would therefore appear that any
conclusions of the benefits of EVR based on good or poor
fitness groups (as defined by m-CPI scores) may not be
appropriate.
The GAS was the only scoring system to show a consistent
increase in risk across tertiles for both morbidity and
mortality. The number of deaths following EVR was small
and caution should be applied to interpretation of mortality
and morbidity data. However, a similar risk profile for early
mortality was demonstrated in 5498 EVR patients enrolled
on the EUROSTAR registry.8 Although the GAS achieved
borderline significance for prediction of early mortalityMorbidity
lue AUC 95% CI p-value
6 0.637 0.51e0.76 0.330
7 0.624 0.51e0.74 0.550
8 0.549 0.42e0.68 0.451
0 0.542 0.41e0.67 0.509
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Figure 2 Post-operative 30-day mortality according to score
tertile.
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Figure 3 Post-operative morbidity according to score tertile.
176 N. Bohm et al.following EVR in our series, the corresponding AUC was low
at 0.68 in ROC analysis, representative of poor accuracy.
This finding is supported by a similar sub-optimal perfor-
mance of the GAS in the EUROSTAR analysis for accuracy
of prediction of early mortality, with an AUC of 0.7.8 Thesepoor performances of the GAS in EVR patients for prediction
of mortality are in contrast to the higher accuracy of the
GAS in predicting mortality following open elective AAA re-
pair, where AUCs of greater than 0.8 have been reported.6,7
Risk Assessment and Endovascular Aneurysm Repair 177Risk-scoring models assessed were based on pre-operative
co-morbidity, generally presumed to be the principle factor
in influencing systemic morbidity and post-operative
mortality following endovascular repair.18 However, ad-
verse anatomic factors that affect technical success also
increase the risks of persistent or recurrent endoleak and
secondary intervention, and are known to have a significant
impact on outcome following EVR. Morphologic characteris-
tics of the proximal aortic neck, particularly neck angula-
tion, are known to influence the effectiveness of aneurysm
exclusion and durability of endograft attachment.19 In
a recent comparative study of patients undergoing EVR
for large (>5.5 cm) or small aneurysms (<5.5 cm), larger
aneurysms were associated with increased type 1 endoleak
and device migration rates, with significantly poorer over-
all survival (71 4.6% versus 86 2.8%; p< 0.001) and in-
creased risk of aneurysm-related death (6.1 2.6% versus
1.5 1.0%; pZ 0.011) at 24 months post EVR.20
Morbidity and mortality following EVR are likely to be
influenced by co-morbid medical conditions, adverse aneu-
rysm morphology and aneurysm size. A global scoring
system combining co-morbidity and anatomic severity
scores has been proposed in the literature, but there are
no published studies validating the performance of such
a model in EVR patients.18
In summary, our study showed little evidence to support
the use of the GAS, V-POSSUM, m-CPI or CPI risk-scoring
models, for prediction of early mortality and morbidity
following EVR. Caution should therefore be applied to the
use of these scoring systems for risk stratification, patient
selection or evaluation of patient benefit following EVR.
Further work may be appropriate in developing a global
risk-scoring system for EVR patients, combining co-morbid
and aneurysm morphological factors.
References
1 Samy AK, Murray G, MacBain G. Glasgow Aneurysm Score.
Cardiovasc Surg 1994;2(1):41e4.
2 Steyerberg EW, Kievit J, de Mol Van Otterloo JCA, Hayo van
Bockel J, Eijkemans MJC, Habbema JDF. Perioperative mortality
of elective abdominal aortic aneurysm repair. Arch Int Med
1995;155:1998e2004.
3 Kertai MD, Boersma E, Klein J, van Urk H, Poldermans D.
Optimizing the prediction of perioperative mortality in vascular
surgery by using a customized probability model. Arch Int Med
2005;165:898e904.
4 Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA,
Cook EF, et al. Derivation and prospective validation of a simple
index for prediction of cardiac risk of major noncardiac surgery.
Circulation 1999;100:1043e9.5 Kertai MD, Steyerberg EW, Boersma E, Bax JJ, Vergouwe Y, van
Urk H, et al. Validation of two risk models for perioperative
mortality in patients undergoing elective abdominal aortic
aneurysm surgery. Vasc Endovasc Surg 2003;37:13e21.
6 Tang TY, Walsh SR, Fanshawe TR, Seppi V, Sadat U, Hayes PD,
et al. Comparison of risk-scoring methods in predicting the
immediate outcome after elective open abdominal aortic aneu-
rysm surgery. Eur J Vasc Endovasc Surg 2007;34:505e13.
7 Biancari F, Leo E, Ylonen K, Vaarala MH, Rainio P, Juvonen T.
Value of the Glasgow Aneurysm Score in predicting the immedi-
ate and long-term outcome after elective open repair of infra-
renal abdominal aortic aneurysm. Br J Surg 2003;90(7):838e44.
8 Biancari F, Hobo R, Juvonen T, EUROSTAR collaborators. Glas-
gow Aneurysm Score predicts survival after endovascular stent-
ing of abdominal aortic aneurysm in patients from the
EUROSTAR registry. Br J Surg 2006;93(2):191e4.
9 Faizer R, DeRose G, Lawlor DJ, Harris KA, Forbes TL. Objective
scoring systems of medical risk: a clinical tool for selecting
patients for open or endovascular abdominal aortic aneurysm
repair. J Vasc Surg 2007;45(6):1102e8.
10 Brown LC. Patient fitness and survival after abdominal aortic
aneurysm repair in patients from the UK EVAR trials: the EVAR
Trial Participants. Br J Surg 2007;94(6):709e16.
11 Prytherch DR, Ridler BM, Beard JD, Earnshaw JJ. A model for
national outcome audit in vascular surgery. Eur J Vasc Endovasc
Surg 2001;21(6):477e83.
12 Tang TY, Walsh SR, Prytherch DR, Wijewardena C, Gaunt ME,
Varty K, et al. POSSUM models in open abdominal aortic aneu-
rysm surgery. Eur J Vasc Endovasc Surg 2007;34:499e504.
13 Smith JJ, Tekkis PP, www.riskprediction.org.uk.
14 Chaikof E, Blankensteijn JD, Harris PL, White GH, Zarins MD,
Bernhard VM, et al. Reporting standards for endovascular aortic
aneurysm repair. J Vasc Surg 2002;35(5):1048e106.
15 Zweig MH, Campbell G. Receiver-operating characteristic (ROC)
plots: a fundamental evaluation tool in clinical medicine. Clin
Chem 1993;39(4):561e77.
16 EVAR trial participants. Endovascular aneurysm repair versus
open repair in patients with abdominal aortic aneurysm: a rand-
omised controlled trial. Lancet 2004;364(9437):843e8.
17 Editorial. Risk models in abdominal aortic aneurysm surgery;
useful for policy makers or patients? Eur J Vasc Endovasc Surg
2007;34:497e8.
18 Chaikof EL, Fillinger MF, Matsumura JS, Rutherford RB,
White GH, Blankenstijn JD, et al. Identifying and grading factors
that modify the outcome of endovascular aortic aneurysm
repair. J Vasc Surg 2002;35(5):1061e6.
19 Albertini J, Kalliafas S, Travis S, Yusuf SW, Macierewicz JA,
Whitaker SC, et al. Anatomical risk factors for proximal peri-
graft endoleak and graft migration following endovascular
repair of abdominal aortic aneurysms. Eur J Vasc Endovasc
Surg 2000;19(3):308e12.
20 Ouriel K, Srivastava SD, Sarac TP, O’hara PJ, Lyden SP,
Greenberg RK, et al. Disparate outcome after endovascular
treatment of small versus large abdominal aortic aneurysm.
J Vasc Surg 2003;37(6):1206e12.
